Maryland Oncology Hematology, PA (145) (USOR SITE)

Columbia, Maryland 21044

0 studies enrolling now · 1 studies all time

What they study most

Solid Tumor, Adult

Studies at this site

• First-in-human Study of IO-108 as Single Agent and in Combination With a PD-1 Immune Check Point Inhibitor in Patients With Advanced Solid Tumors — Completed